Complications associated with the treatment of haemophiliacs with inhibitors.
about
Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patientsThe future of plasma-derived clotting factor concentrates.Therapeutic choices for patients with hemophilia and high-titer inhibitors.Anti-inhibitor coagulant complex for the rescue therapy of acquired inhibitors to factor VIII: case report and review of the literature.Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors.An overview of the history, clinical practice concerns, comparative studies and strategies to optimize therapy of bypassing agents.Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors.Efficacy of NovoSeven during surgery on a haemophiliac with previous history of inhibitors.IgE-mediated anaphylactic reaction to purified and recombinant factor VIII in a patient with severe haemophilia A.Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors.Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia.Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events.
P2860
Q33959616-15FE205D-DE79-4BCB-B868-0DE9F22EA774Q34176013-AE9C0F1C-084A-4A44-AD6E-F79B28658307Q34302267-CD70F08A-FAA9-4D42-926B-F4791060C1D9Q34801396-EB25154A-FD10-47BF-BA0E-34C64D58872DQ35771690-E425FD3E-6B16-4606-A284-A9F748F68943Q36661836-32EBF024-4664-44EE-8897-3F954F3589C5Q36828144-D07DF824-AD90-40ED-BDB1-B84F3A1C1069Q45858257-5814DBA8-4BAE-4394-8E0D-0D81AC48C243Q45864945-248C6D54-485F-44BC-B40B-7170F5EDF8ADQ45868039-CA7C5FC5-F3A9-4203-B473-998FA1D03106Q45876598-506BB388-71FB-4444-AEEF-0085033F4BD6Q45884124-3464172D-766D-43F5-A9A2-44709DA96A79Q45885101-D0943177-C2BE-4D73-8DD3-5A4231C0C900
P2860
Complications associated with the treatment of haemophiliacs with inhibitors.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Complications associated with the treatment of haemophiliacs with inhibitors.
@ast
Complications associated with the treatment of haemophiliacs with inhibitors.
@en
Complications associated with the treatment of haemophiliacs with inhibitors.
@nl
type
label
Complications associated with the treatment of haemophiliacs with inhibitors.
@ast
Complications associated with the treatment of haemophiliacs with inhibitors.
@en
Complications associated with the treatment of haemophiliacs with inhibitors.
@nl
prefLabel
Complications associated with the treatment of haemophiliacs with inhibitors.
@ast
Complications associated with the treatment of haemophiliacs with inhibitors.
@en
Complications associated with the treatment of haemophiliacs with inhibitors.
@nl
P2860
P1433
P1476
Complications associated with the treatment of haemophiliacs with inhibitors.
@en
P2093
P2860
P356
10.1046/J.1365-2516.1999.00032.X
P478
P577
1999-09-01T00:00:00Z